DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test
Welcome to DNA Labs UAE, where we offer the DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test. This test is designed to diagnose and manage a rare genetic disorder that affects the neuromuscular junction, resulting in muscle weakness and fatigue.
Test Components
The DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test includes the following components:
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Neurological Disorders
- Doctor: Neurologist
- Test Department: Genetics
Pre Test Information
Before undergoing the DOK7 Gene Myasthenic Syndrome Congenital Type 10 Genetic Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session will be conducted to draw a pedigree chart of family members affected with this genetic disorder.
Test Details
The DOK7 gene myasthenic syndrome, congenital, type 10 is a rare genetic disorder that affects the neuromuscular junction. It is caused by mutations in the DOK7 gene, which plays a role in the formation and maintenance of the neuromuscular junction.
NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or changes in genes that may be responsible for a particular disorder or condition. In the case of DOK7 gene myasthenic syndrome, congenital, type 10, NGS genetic testing can be used to analyze the DOK7 gene and identify any mutations or variants that may be present.
NGS genetic testing involves sequencing the DNA of an individual and comparing it to a reference genome to identify any differences. This can help determine if there are any mutations or variants in the DOK7 gene associated with the development of the disorder.
NGS genetic testing can be useful in confirming a diagnosis of DOK7 gene myasthenic syndrome, congenital, type 10, especially in cases where the clinical presentation is unclear or atypical. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known DOK7 gene mutation.
Overall, NGS genetic testing for DOK7 gene myasthenic syndrome, congenital, type 10 can provide valuable information for diagnosis, genetic counseling, and management of the condition.
Test Name | DOK7 Gene Myasthenic syndrome congenital type 10 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card o |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Neurological Disorders |
Doctor | Neurologist |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for DOK7 Gene Myasthenic syndrome, congenital, type 10 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with DOK7 Gene Myasthenic syndrome, congenital, type 10 |
Test Details |
DOK7 gene myasthenic syndrome, congenital, type 10 is a rare genetic disorder that affects the neuromuscular junction, resulting in muscle weakness and fatigue. It is caused by mutations in the DOK7 gene, which is involved in the formation and maintenance of the neuromuscular junction. NGS (Next-Generation Sequencing) genetic testing is a diagnostic tool used to identify mutations or changes in genes that may be responsible for a particular disorder or condition. In the case of DOK7 gene myasthenic syndrome, congenital, type 10, NGS genetic testing can be used to analyze the DOK7 gene and identify any mutations or variants that may be present. NGS genetic testing involves sequencing the DNA of an individual and comparing it to a reference genome to identify any differences. This can help to determine if there are any mutations or variants in the DOK7 gene that are associated with the development of the disorder. NGS genetic testing can be useful in confirming a diagnosis of DOK7 gene myasthenic syndrome, congenital, type 10, particularly in cases where the clinical presentation is unclear or atypical. It can also be used for carrier testing in individuals with a family history of the disorder or for prenatal testing in families with a known DOK7 gene mutation. Overall, NGS genetic testing for DOK7 gene myasthenic syndrome, congenital, type 10 can provide valuable information for diagnosis, genetic counseling, and management of the condition. |